By inhibiting the TXNIP/NLRP3 pathways and improving autophagic clearance, transdermal application of Vera@CLCMP patches alleviated obesity-induced insulin resistance and hepatic steatosis. This evidence concerns the gene NLRP3 and Insulin resistance.